Literature DB >> 9056422

Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells.

M A Guvakova1, E Surmacz.   

Abstract

The insulin-like growth factor I receptor (IGF-IR) paracrine or autocrine loop plays an important role in the maintenance of breast cancer growth. Cancer cells contain several-fold higher levels of the IGF-IR than normal breast tissue; however, it is still not clear whether abnormally high activation of IGF-IR signaling may induce progression of the disease. To address this question, we have established several MCF-7-derived clones (MCF-7/IGF-IR cells) overexpressing the IGF-IR. We report here that overexpression of the IGF-IR did not modify sensitivity of cells to IGF-I; however, responsiveness to the ligand was moderately enhanced in most of the MCF-7/IGF-IR clones (measured by [3H]thymidine incorporation into DNA). All MCF-7/IGF-IR clones responded to the synergistic action of 1 nM estradiol (E2) and small amounts of IGF-I (up to 0.8 ng/ml). Exposure of cells to higher concentrations of IGF-I abolished estrogen requirements for stimulation of DNA synthesis in all MCF-7/IGF-IR clones, but not in the parental cells. The most important finding of this work was that the amplification of the IGF-IR induced cell-cell adhesion in MCF-7 cells. High levels of the IGF-IR promoted cell aggregation on Matrigel, allowed proliferation of cells within the aggregates, and protected clustered cells from death. In both MCF-7 and MCF-7/IGF-IR cells, IGF-I stimulated aggregation, whereas an anti-E cadherin antibody blocked cell-cell adhesion. Furthermore, immunofluorescence staining with specific antibodies revealed co-localization of the IGF-IR and E-cadherin at the points of cell-cell contacts. Moreover, the IGF-IR and its two substrates, insulin receptor substrate 1 and SHC, were contained within the E-cadherin complexes. Our results suggest that overexpressed IGF-IRs, by promoting the aggregation, growth, and survival of breast cancer cells, may accelerate the increase of tumor mass and may also prevent cell scattering.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9056422     DOI: 10.1006/excr.1996.3457

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  32 in total

1.  Nuclear IGF1R is a transcriptional co-activator of LEF1/TCF.

Authors:  Dudi Warsito; Sylvia Sjöström; Sandra Andersson; Olle Larsson; Bita Sehat
Journal:  EMBO Rep       Date:  2012-03-01       Impact factor: 8.807

2.  A novel role for FGF and extracellular signal-regulated kinase in gap junction-mediated intercellular communication in the lens.

Authors:  A C Le; L S Musil
Journal:  J Cell Biol       Date:  2001-07-09       Impact factor: 10.539

3.  Overexpression of insulin-like growth factor II (IGFII) in ZR-75-1 human breast cancer cells: higher threshold levels of receptor (IGFIR) are required for a proliferative response than for effects on specific gene expression.

Authors:  K Abdul-Wahab; D Corcoran; A Perachiotti; P D Darbre
Journal:  Cell Prolif       Date:  1999-10       Impact factor: 6.831

4.  Loss of E-cadherin Enhances IGF1-IGF1R Pathway Activation and Sensitizes Breast Cancers to Anti-IGF1R/InsR Inhibitors.

Authors:  Alison M Nagle; Kevin M Levine; Nilgun Tasdemir; Julie A Scott; Kara Burlbaugh; Justin Kehm; Tiffany A Katz; David N Boone; Britta M Jacobsen; Jennifer M Atkinson; Steffi Oesterreich; Adrian V Lee
Journal:  Clin Cancer Res       Date:  2018-06-25       Impact factor: 12.531

5.  The insulin-like growth factor receptor I promotes motility and invasion of bladder cancer cells through Akt- and mitogen-activated protein kinase-dependent activation of paxillin.

Authors:  David Metalli; Francesca Lovat; Farida Tripodi; Marco Genua; Shi-Qiong Xu; Michela Spinelli; Lilia Alberghina; Marco Vanoni; Raffaele Baffa; Leonard G Gomella; Renato V Iozzo; Andrea Morrione
Journal:  Am J Pathol       Date:  2010-04-15       Impact factor: 4.307

Review 6.  Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: new insights into their synergistic effects.

Authors:  J Dupont; D Le Roith
Journal:  Mol Pathol       Date:  2001-06

Review 7.  Tamoxifen resistance in breast cancer: elucidating mechanisms.

Authors:  L C Dorssers; S Van der Flier; A Brinkman; T van Agthoven; J Veldscholte; E M Berns; J G Klijn; L V Beex; J A Foekens
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 8.  IGF-I receptor, cell-cell adhesion, tumour development and progression.

Authors:  Loredana Mauro; Eva Surmacz
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

9.  Disease evidence for IGFBP-2 as a key player in prostate cancer progression and development of osteosclerotic lesions.

Authors:  David J Degraff; Adam A Aguiar; Robert A Sikes
Journal:  Am J Transl Res       Date:  2009-01-20       Impact factor: 4.060

10.  Nuclear IRS-1 predicts tamoxifen response in patients with early breast cancer.

Authors:  Ilenia Migliaccio; Meng-Fen Wu; Carolina Gutierrez; Luca Malorni; Syed K Mohsin; D Craig Allred; Susan G Hilsenbeck; C Kent Osborne; Heidi Weiss; Adrian V Lee
Journal:  Breast Cancer Res Treat       Date:  2009-11-19       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.